LSP’s portfolio company Neuravi acquired by Codman Neuro



Amsterdam, the Netherlands, April 10, 2017 – LSP (Life Sciences Partners), a leading European investor in health care, announces the acquisition of its portfolio company Neuravi Limited by Codman Neuro, part of the Johnson & Johnson Family of Medical Device Companies. Neuravi is a privately held Irish company dedicated to advancing neurointerventional therapies and improving clinical outcomes for acute ischemic stroke patients.
 
The press release of Codman Neuro related to this transaction can be found here.
 
Contact:
Anne Portwich, PhD
Partner
Tel.: +31 20 664 5500
ncbegjvpu@yfcip.pbz

Dr René Kuijten 
Managing Partner
Tel: +31 20 664 5500
 
About LSP
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over USD 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors. For more information, please visit www.lspvc.com.
« back to overview

LSP’s portfolio company Neuravi acquired by Codman Neuro



Amsterdam, the Netherlands, April 10, 2017 – LSP (Life Sciences Partners), a leading European investor in health care, announces the acquisition of its portfolio company Neuravi Limited by Codman Neuro, part of the Johnson & Johnson Family of Medical Device Companies. Neuravi is a privately held Irish company dedicated to advancing neurointerventional therapies and improving clinical outcomes for acute ischemic stroke patients.
 
The press release of Codman Neuro related to this transaction can be found here.
 
Contact:
Anne Portwich, PhD
Partner
Tel.: +31 20 664 5500
ncbegjvpu@yfcip.pbz

Dr René Kuijten 
Managing Partner
Tel: +31 20 664 5500
 
About LSP
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over USD 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors. For more information, please visit www.lspvc.com.
« back to overview